UCB SA Announces Dividend of $0.46 (OTCMKTS:UCBJY)

UCB SA (OTCMKTS:UCBJY) announced a dividend on Friday, April 19th, investing.com reports. Shareholders of record on Monday, April 29th will be paid a dividend of 0.4574 per share on Wednesday, May 15th. This represents a dividend yield of 0.71%. The ex-dividend date is Friday, April 26th.

UCB Stock Performance

Shares of UCBJY opened at $63.68 on Friday. UCB has a 1 year low of $34.85 and a 1 year high of $65.00. The stock’s fifty day moving average price is $58.20 and its two-hundred day moving average price is $47.18.

About UCB

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies.